Klaus Martin

Klaus Martin

Company: Topas Therapeutics

Job title: Chief Executive Officer

Seminars:

A nanoparticle platform for multiple immune tolerance therapies 3:00 pm

Broad therapeutic potential of our proprietary Topas Particle Conjugates delivering peptide antigens to special liver cells Diverse mechanism-of-action through different immune pathways to rebalance the immune system Pemphigus vulgaris and Celiac disease as strong clinical modelsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.